| Afifi et al [52], 2021 |
21 residents (female: n=18, male: n=3; mean age 83.1, SD 3.72 y) with their family members (female: n=9, male: n=12; mean age 59.86, SD 14.12 y)
|
|
|
| Baker et al [53], 2021 |
|
|
|
| Coelho et al [40], 2020 |
|
Dementia (n=9)
Moderate cognitive decline (n=3)
Moderately severe cognitive decline (n=3)
Severe cognitive decline (n=3)
|
|
| Huang and Yang [54], 2022 |
20 participants (female: n=11, male: n=9; mean age 79.0, SD 7.8 y)
Among the 20 participants, 7 were assessed 3-6 mo after the intervention
|
Very mild dementia (n=2)
Mild dementia (n=15)
Moderate dementia (n=3)
|
|
| Klein et al [25], 2018 |
|
|
|
| Niki et al [55], 2020 |
|
|
|
| Saredakis et al [56], 2020 |
|
No or minimal cognitive impairment (n=10)
Mild cognitive impairments (n=3)
Moderate cognitive impairments (n=4)
|
|
| Saredakis et al [57], 2021 |
Experiment group: 15 participants (female: n=10, male: n=5; mean age 81.7, SD 6.6 y)
Active control: 14 participants (female: n=9, male: n=5; mean age 85.9, SD 8.1 y)
Passive control: 14 participants (female: n=9, male: n=5; mean age 87, SD 8.7 y)
Total: 43 participants (female: n=28, male: n=15; mean age 84.8, SD 8 y)
|
Memory-related dementia or Parkinson disease (n=5)
Memory-related dementia or Parkinson disease (n=3)
Memory-related, dementia or Parkinson disease (n=3)
Memory-related dementia or Parkinson disease (n=11)
|
Depression (n=5)
Anxiety (n=5)
Heart disease (n=8)
Stroke (n=2)
|
| Webber et al [58], 2021 |
|
|
|
| Xu and Wang [59], 2020 |
Virtual reality–based group: 10 participants (female: n=5, male: n=5; mean age 76.7, SD 5.5 y)
Photo-based group: 10 participants (female: n=8, male: n=3; mean age 79.4, SD 2.0 y)
Blank group (verbally guided): 10 participants (mean age 78.5, SD 3.4 y)
|
|
|
| Yahara et al [60], 2021 |
|
|
|